Searched for
SAVINGS ON CANCER TREATMENT
Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annuallyStarting November 9, consumers in India will benefit from significantly reduced prices on 137 anti-cancer drugs. The government has capped ...- Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...
- His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccinesHyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technol...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%Oil prices matter to the Indian economy, and the market responded with a smart rally as Brent crude cooled significantly on Monday. The ral...
- Lighting lives beyond Diwali: How everyday Indians are making a difference through givingAn RBI officer, a Bengaluru retailer, a safari lodge owner and a 24-year-old money coach tell us how giving a little, steadily, lights some...
- NPPA list brings little relief: No price cut for 25% cancer drugsNearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across ...
- Cancer care can be cheaper: 6 steps to cut drug costsIndia has capped trade margins at 30% on 137 non-scheduled anti-cancer drugs to reduce treatment costs. Experts call for standardised care,...
- Rs 1 lakh to Rs 30,000: Cancer immunotherapy gets cheaper, but will patients get the price benefit?Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up 32%, according to analystsHistory tells us that there is no way you can time the markets or predict its movement. But one thing can certainly be said: If the macro m...
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...
- Eyes now on Viksit, net zero later: Can India achieve high-income status by 2047 without compromising on climate promises?India aims to achieve a high-income economy status by 2047, requiring substantial economic growth and investment. However, ambitious climat...
- LIC reveals details of its 3 new plans: Check benefits of New Jeevan Dhara-II, Health Shield and New Cancer CoverLife Insurance Corporation of India is set to launch three new insurance products on October 19, 2026. These offerings, namely New Jeevan D...
- Protect patients and patents smartlyThe Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...
- Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possibleAn expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...
- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- Lance Armstrong net worth, salary, earnings, wealth: Rise and fall of once iconic American cyclist, face of prestigious Tour de France and investment lessons from Olympic medalistLance Armstrong during his peak had signed major endorsements with Nike, Oakley, Trek and Anheuser Busch. Armstrong said that he lost about...
- Nobel 2026: Ozempic, Mounjaro research tipped for medicine prizeThe 2026 Nobel season is set to reveal the winners of various prestigious awards, starting with medicine. The medicine prize is anticipated...
- Karnataka flags 52x mark-up on cancer drugs, seeks Centre's interventionKarnataka conducted inspections revealing significant price disparities between hospital procurement and patient billing for cancer drugs a...
Load More
